Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
奈拉替尼对HER2突变型晚期胆道癌患者的抗肿瘤活性
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-36399-y
Harding, James J; Piha-Paul, Sarina A; Shah, Ronak H; Murphy, Jessica J; Cleary, James M; Shapiro, Geoffrey I; Quinn, David I; Braña, Irene; Moreno, Victor; Borad, Mitesh; Loi, Sherene; Spanggaard, Iben; Park, Haeseong; Ford, James M; Arnedos, Mónica; Stemmer, Salomon M; de la Fouchardiere, Christelle; Fountzilas, Christos; Zhang, Jie; DiPrimeo, Daniel; Savin, Casey; Duygu Selcuklu, S; Berger, Michael F; Eli, Lisa D; Meric-Bernstam, Funda; Jhaveri, Komal; Solit, David B; Abou-Alfa, Ghassan K